Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Concord Drugs Ltd.	LIVE QUOTES

BSE: 538965ISIN: INE858L01010INDUSTRY: Pharmaceuticals

BSE

Rs 64.21

Open: 64.21

Today's Range 64.21

64.21

+3.05 (+ 4.75 %)

Prev Close: 61.16

52 Week Range 26.10

64.21

Registered Address

Registered Office : Survey No.249, , Brahmanpally Village, Hayatnagar Mandal,

R R District, Telangana - 501511

Tel: 040-24036379, 24037763

Fax: 040-24037763

Email : concorddrugsltd@gmail.com

Website : http://www.concorddrugs.in

Key Officials

Name	Designation
Ms. Namratha Nagla	Co. Secretary & Compl. Officer

Listings

BSE ,

StandaloneConsolidated

Quarterly Trends - Standalone

Rs. in Crs.

Financial Year	Mar 25	Dec 24	Sep 24
Sales	7.96	10.77	11.84
Other Income	0.00	0.00	0.01
Total Expenses	7.04	9.46	11.05
Depreciation	0.37	0.37	0.34
Taxation	0.01	0.30	0.02
Net Profit / Loss	0.01	0.22	0.05
Equity Capital	10.00	10.00	10.00

Half Yearly Balance Sheet - Standalone

Rs. in Crs.

YearEnding	Mar 25	Mar 24	Mar 23
Face Value	10	10	10
Equity Share Capital	10.00	10.00	9.32
Reserves and Surplus	24.11	23.82	22.39
Total Non-Current Liabilities	4.84	3.04	4.03
Total Current Liabilities	19.62	19.44	20.90
Total Capital And Liabilities	58.58	56.30	56.63
Total Non-Current Assets	25.16	14.92	15.23
Total Current Assets	33.42	41.38	41.40
Total Assets	58.58	56.30	56.63

Quarterly Trends - Consolidated

Rs. in Crs.

Financial Year	Mar 25	Dec 24	Sep 24
Sales	10.39	10.80	12.36
Other Income	0.00	0.00	0.01
Total Expenses	9.36	9.39	11.50
Depreciation	0.38	0.37	0.34
Taxation	0.02	0.30	0.02
Net Profit / Loss	0.04	0.23	0.04
Equity Capital	10.00	10.00	10.00

Half Yearly Balance Sheet - Consolidated

Rs. in Crs.

YearEnding	Mar 25	Mar 24	Mar 23
Face Value	10	10	10
Equity Share Capital	10.00	10.00	9.32
Reserves and Surplus	24.11	23.82	22.39
Total Non-Current Liabilities	4.85	3.65	4.91
Total Current Liabilities	26.18	21.34	21.61
Total Capital And Liabilities	65.14	58.81	58.23
Total Non-Current Assets	24.38	14.19	14.77
Total Current Assets	40.76	44.62	43.46
Total Assets	65.14	58.81	58.23

Corporate News

Concord Drugs - Compliances-Certificate under Reg. 74 (5) of...

Concord Drugs - Notice Of EGM

Concord Drugs - Announcement under Regulation 30 (LODR)-Amen...

Concord Drugs - Board Meeting Outcome for Out Come Of Board ...

Concord Drugs - Clarification Letter Sought From BSE

Registrar Details

Aarthi Consultants Pvt Ltd

1-2-285, Domalguda

Hyderabad,500029,Telangana

Tel : 040-27638111

Fax : 27632184

BSE

Market Performance

Exchange	BSE
Last Traded Price (Rs.)	64.21
Last Traded Date	11/07/2025
Last Traded Time	-
Change (%)	4.99%
Day's Open (Rs.)	64.21
Previous Close (Rs.)	61.16
Day's High (Rs.)	64.21
Day's Low (Rs.)	64.21
Total Traded Qty	45282
Value (Rs. In Lacs)	29.08
Bid Price (Rs.)	0.00
Bid Quantity
Offer Price (Rs.)	0.00
Offer Quantity
Exchange Code	538965
Exchange Group	XT

Board Meetings

Date	Purpose
03/07/2025	Preferential issue of shares
27/06/2025	Preferential Issue of shares & Others
23/05/2025	Audited Results

Share Holding Pattern as on 31/03/2025

Major Holder	No. of Shares	Percentage (%)
Promoters	5,439,204	54.39
Institutional Investors	0	0.00
Other Investors	227,736	2.28
General Public	4,333,060	43.33

Market

Derivatives

Mutual Fund

IPO

Quick Links

Concord Drugs Ltd.

LIVE QUOTES